世界のエポプロステノール市場 2019年

【英語タイトル】Global Epoprostenol Market Professional Survey Report 2019

QYResearchが出版した調査資料(DATA909X07398)・商品コード:DATA909X07398
・発行会社(調査会社):QYResearch
・発行日:2019年11月15日(※2024年版があります。お問い合わせください)
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、エポプロステノールの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口、注射に、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、エポプロステノールの世界市場を分析しました。


・エグゼクティブ・サマリー
・エポプロステノールの世界市場概要
・エポプロステノールの製造コスト構成分析
・エポプロステノールの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・エポプロステノールの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・エポプロステノールのセグメント分析(種類別)
(経口、注射)
・エポプロステノールのセグメント分析(用途別)
(病院薬局、小売薬局、オンライン薬局)
・エポプロステノールの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Actelion、Glaxosmithkline Inc、Sandoz Canada Incorporated、Teva Parenteral、Bayer AG、SteadyMed、Reata Pharmaceuticals、Arena Pharmaceuticals、Merck、)
・エポプロステノールの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Epoprostenol market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Epoprostenol volume and value at global level, regional level and company level. From a global perspective, this report represents overall Epoprostenol market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Epoprostenol in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Epoprostenol manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Actelion
Glaxosmithkline Inc
Sandoz Canada Incorporated
Teva Parenteral
Bayer AG
SteadyMed
Reata Pharmaceuticals
Arena Pharmaceuticals
Merck

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral
Injection

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Epoprostenol
1.1 Definition of Epoprostenol
1.2 Epoprostenol Segment by Type
1.2.1 Global Epoprostenol Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Injection
1.3 Epoprostenol Segment by Applications
1.3.1 Global Epoprostenol Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Epoprostenol Overall Market
1.4.1 Global Epoprostenol Revenue (2014-2025)
1.4.2 Global Epoprostenol Production (2014-2025)
1.4.3 North America Epoprostenol Status and Prospect (2014-2025)
1.4.4 Europe Epoprostenol Status and Prospect (2014-2025)
1.4.5 China Epoprostenol Status and Prospect (2014-2025)
1.4.6 Japan Epoprostenol Status and Prospect (2014-2025)
1.4.7 Southeast Asia Epoprostenol Status and Prospect (2014-2025)
1.4.8 India Epoprostenol Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Epoprostenol
2.3 Manufacturing Process Analysis of Epoprostenol
2.4 Industry Chain Structure of Epoprostenol

3 Development and Manufacturing Plants Analysis of Epoprostenol
3.1 Capacity and Commercial Production Date
3.2 Global Epoprostenol Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Epoprostenol
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Epoprostenol Production and Capacity Analysis
4.2 Epoprostenol Revenue Analysis
4.3 Epoprostenol Price Analysis
4.4 Market Concentration Degree

5 Epoprostenol Regional Market Analysis
5.1 Epoprostenol Production by Regions
5.1.1 Global Epoprostenol Production by Regions
5.1.2 Global Epoprostenol Revenue by Regions
5.2 Epoprostenol Consumption by Regions
5.3 North America Epoprostenol Market Analysis
5.3.1 North America Epoprostenol Production
5.3.2 North America Epoprostenol Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Epoprostenol Import and Export
5.4 Europe Epoprostenol Market Analysis
5.4.1 Europe Epoprostenol Production
5.4.2 Europe Epoprostenol Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Epoprostenol Import and Export
5.5 China Epoprostenol Market Analysis
5.5.1 China Epoprostenol Production
5.5.2 China Epoprostenol Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Epoprostenol Import and Export
5.6 Japan Epoprostenol Market Analysis
5.6.1 Japan Epoprostenol Production
5.6.2 Japan Epoprostenol Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Epoprostenol Import and Export
5.7 Southeast Asia Epoprostenol Market Analysis
5.7.1 Southeast Asia Epoprostenol Production
5.7.2 Southeast Asia Epoprostenol Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Epoprostenol Import and Export
5.8 India Epoprostenol Market Analysis
5.8.1 India Epoprostenol Production
5.8.2 India Epoprostenol Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Epoprostenol Import and Export

6 Epoprostenol Segment Market Analysis (by Type)
6.1 Global Epoprostenol Production by Type
6.2 Global Epoprostenol Revenue by Type
6.3 Epoprostenol Price by Type

7 Epoprostenol Segment Market Analysis (by Application)
7.1 Global Epoprostenol Consumption by Application
7.2 Global Epoprostenol Consumption Market Share by Application (2014-2019)

8 Epoprostenol Major Manufacturers Analysis
8.1 Actelion
8.1.1 Actelion Epoprostenol Production Sites and Area Served
8.1.2 Actelion Product Introduction, Application and Specification
8.1.3 Actelion Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Glaxosmithkline Inc
8.2.1 Glaxosmithkline Inc Epoprostenol Production Sites and Area Served
8.2.2 Glaxosmithkline Inc Product Introduction, Application and Specification
8.2.3 Glaxosmithkline Inc Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sandoz Canada Incorporated
8.3.1 Sandoz Canada Incorporated Epoprostenol Production Sites and Area Served
8.3.2 Sandoz Canada Incorporated Product Introduction, Application and Specification
8.3.3 Sandoz Canada Incorporated Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Teva Parenteral
8.4.1 Teva Parenteral Epoprostenol Production Sites and Area Served
8.4.2 Teva Parenteral Product Introduction, Application and Specification
8.4.3 Teva Parenteral Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bayer AG
8.5.1 Bayer AG Epoprostenol Production Sites and Area Served
8.5.2 Bayer AG Product Introduction, Application and Specification
8.5.3 Bayer AG Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 SteadyMed
8.6.1 SteadyMed Epoprostenol Production Sites and Area Served
8.6.2 SteadyMed Product Introduction, Application and Specification
8.6.3 SteadyMed Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Reata Pharmaceuticals
8.7.1 Reata Pharmaceuticals Epoprostenol Production Sites and Area Served
8.7.2 Reata Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Reata Pharmaceuticals Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Arena Pharmaceuticals
8.8.1 Arena Pharmaceuticals Epoprostenol Production Sites and Area Served
8.8.2 Arena Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Arena Pharmaceuticals Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Merck
8.9.1 Merck Epoprostenol Production Sites and Area Served
8.9.2 Merck Product Introduction, Application and Specification
8.9.3 Merck Epoprostenol Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Epoprostenol Market
9.1 Global Epoprostenol Market Trend Analysis
9.1.1 Global Epoprostenol Market Size (Volume and Value) Forecast 2019-2025
9.2 Epoprostenol Regional Market Trend
9.2.1 North America Epoprostenol Forecast 2019-2025
9.2.2 Europe Epoprostenol Forecast 2019-2025
9.2.3 China Epoprostenol Forecast 2019-2025
9.2.4 Japan Epoprostenol Forecast 2019-2025
9.2.5 Southeast Asia Epoprostenol Forecast 2019-2025
9.2.6 India Epoprostenol Forecast 2019-2025
9.3 Epoprostenol Market Trend (Product Type)
9.4 Epoprostenol Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Epoprostenol Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Epoprostenol
Table Global Epoprostenol Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Epoprostenol Production Market Share by Types in 2018
Figure Oral Product Picture
Figure Injection Product Picture
Table Global Epoprostenol Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Epoprostenol Consumption Market Share by Applications in 2018
Figure Hospital Pharmacy
Figure Retail Pharmacy
Figure Online Pharmacy
Figure Global Epoprostenol Revenue (Million USD) (2014-2025)
Figure Global Epoprostenol Production (K Units) (2014-2025)
Figure North America Epoprostenol Market Size (Million USD) (2014-2025)
Figure Europe Epoprostenol Market Size (Million USD) (2014-2025)
Figure China Epoprostenol Market Size (Million USD) (2014-2025)
Figure Japan Epoprostenol Market Size (Million USD) (2014-2025)
Figure Southeast Asia Epoprostenol Market Size (Million USD) (2014-2025)
Figure India Epoprostenol Market Size (Million USD) (2014-2025)
Table Epoprostenol Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Epoprostenol in 2018
Figure Manufacturing Process Analysis of Epoprostenol
Figure Industry Chain Structure of Epoprostenol
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Epoprostenol Manufacturing Plants Distribution
Table Epoprostenol Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Epoprostenol Capacity (K Units) of Major Manufacturers (2014-2019)
Table Epoprostenol Production (K Units) of Major Manufacturers (2014-2019)
Table Epoprostenol Production Market Share of Major Manufacturers (2014-2019)
Figure Epoprostenol Production Share by Manufacturers in 2018
Table Epoprostenol Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Epoprostenol Revenue Market Share of Major Manufacturers (2014-2019)
Figure Epoprostenol Revenue Share by Manufacturers in 2018
Table Epoprostenol Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Epoprostenol Production by Regions 2014-2019 (K Units)
Table Global Epoprostenol Production Market Share by Regions 2014-2019
Figure Global Epoprostenol Production Market Share by Regions in 2018
Table Global Epoprostenol Revenue by Regions 2014-2019 (Million USD)
Table Global Epoprostenol Revenue Market Share by Regions 2014-2019
Figure Global Epoprostenol Revenue Market Share by Regions in 2018
Table Global Epoprostenol Consumption by Regions 2014-2019 (K Units)
Table Global Epoprostenol Consumption Market Share by Regions 2014-2019
Figure North America Epoprostenol Production Growth Rate 2014-2019 (K Units)
Figure North America Epoprostenol Revenue Growth Rate 2014-2019 (Million USD)
Table North America Epoprostenol Production, Consumption Import and Export (K Units)
Figure Europe Epoprostenol Production Growth Rate 2014-2019 (K Units)
Figure Europe Epoprostenol Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Epoprostenol Production, Consumption Import and Export (K Units)
Figure China Epoprostenol Production Growth Rate 2014-2019 (K Units)
Figure China Epoprostenol Revenue Growth Rate 2014-2019 (Million USD)
Table China Epoprostenol Production, Consumption Import and Export (K Units)
Figure Japan Epoprostenol Production Growth Rate 2014-2019 (K Units)
Figure Japan Epoprostenol Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Epoprostenol Production, Consumption Import and Export (K Units)
Figure Southeast Asia Epoprostenol Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Epoprostenol Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Epoprostenol Production, Consumption Import and Export (K Units)
Figure India Epoprostenol Production Growth Rate 2014-2019 (K Units)
Figure India Epoprostenol Revenue Growth Rate 2014-2019 (Million USD)
Table India Epoprostenol Production, Consumption Import and Export (K Units)
Figure Global Consumption Epoprostenol Market Share by Application (2014-2019)
Figure Global Value (Consumption) Epoprostenol Market Share by Application (2014-2019)
Table Actelion Epoprostenol Production Sites and Area Served
Table Actelion Epoprostenol Product Introduction, Application and Specification
Table Actelion Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Actelion Epoprostenol Production Growth Rate (2014-2019)
Table Actelion Epoprostenol Production Market Share (2014-2019)
Figure Actelion Epoprostenol Revenue Market Share (2014-2019)
Table Actelion Epoprostenol Main Business and Markets Served
Table Glaxosmithkline Inc Epoprostenol Production Sites and Area Served
Table Glaxosmithkline Inc Epoprostenol Product Introduction, Application and Specification
Table Glaxosmithkline Inc Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Glaxosmithkline Inc Epoprostenol Production Growth Rate (2014-2019)
Table Glaxosmithkline Inc Epoprostenol Production Market Share (2014-2019)
Figure Glaxosmithkline Inc Epoprostenol Revenue Market Share (2014-2019)
Table Glaxosmithkline Inc Epoprostenol Main Business and Markets Served
Table Sandoz Canada Incorporated Epoprostenol Production Sites and Area Served
Table Sandoz Canada Incorporated Epoprostenol Product Introduction, Application and Specification
Table Sandoz Canada Incorporated Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sandoz Canada Incorporated Epoprostenol Production Growth Rate (2014-2019)
Table Sandoz Canada Incorporated Epoprostenol Production Market Share (2014-2019)
Figure Sandoz Canada Incorporated Epoprostenol Revenue Market Share (2014-2019)
Table Sandoz Canada Incorporated Epoprostenol Main Business and Markets Served
Table Teva Parenteral Epoprostenol Production Sites and Area Served
Table Teva Parenteral Epoprostenol Product Introduction, Application and Specification
Table Teva Parenteral Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Parenteral Epoprostenol Production Growth Rate (2014-2019)
Table Teva Parenteral Epoprostenol Production Market Share (2014-2019)
Figure Teva Parenteral Epoprostenol Revenue Market Share (2014-2019)
Table Teva Parenteral Epoprostenol Main Business and Markets Served
Table Bayer AG Epoprostenol Production Sites and Area Served
Table Bayer AG Epoprostenol Product Introduction, Application and Specification
Table Bayer AG Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Epoprostenol Production Growth Rate (2014-2019)
Table Bayer AG Epoprostenol Production Market Share (2014-2019)
Figure Bayer AG Epoprostenol Revenue Market Share (2014-2019)
Table Bayer AG Epoprostenol Main Business and Markets Served
Table SteadyMed Epoprostenol Production Sites and Area Served
Table SteadyMed Epoprostenol Product Introduction, Application and Specification
Table SteadyMed Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table SteadyMed Epoprostenol Production Growth Rate (2014-2019)
Table SteadyMed Epoprostenol Production Market Share (2014-2019)
Figure SteadyMed Epoprostenol Revenue Market Share (2014-2019)
Table SteadyMed Epoprostenol Main Business and Markets Served
Table Reata Pharmaceuticals Epoprostenol Production Sites and Area Served
Table Reata Pharmaceuticals Epoprostenol Product Introduction, Application and Specification
Table Reata Pharmaceuticals Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Reata Pharmaceuticals Epoprostenol Production Growth Rate (2014-2019)
Table Reata Pharmaceuticals Epoprostenol Production Market Share (2014-2019)
Figure Reata Pharmaceuticals Epoprostenol Revenue Market Share (2014-2019)
Table Reata Pharmaceuticals Epoprostenol Main Business and Markets Served
Table Arena Pharmaceuticals Epoprostenol Production Sites and Area Served
Table Arena Pharmaceuticals Epoprostenol Product Introduction, Application and Specification
Table Arena Pharmaceuticals Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Arena Pharmaceuticals Epoprostenol Production Growth Rate (2014-2019)
Table Arena Pharmaceuticals Epoprostenol Production Market Share (2014-2019)
Figure Arena Pharmaceuticals Epoprostenol Revenue Market Share (2014-2019)
Table Arena Pharmaceuticals Epoprostenol Main Business and Markets Served
Table Merck Epoprostenol Production Sites and Area Served
Table Merck Epoprostenol Product Introduction, Application and Specification
Table Merck Epoprostenol Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Epoprostenol Production Growth Rate (2014-2019)
Table Merck Epoprostenol Production Market Share (2014-2019)
Figure Merck Epoprostenol Revenue Market Share (2014-2019)
Table Merck Epoprostenol Main Business and Markets Served
Figure Global Epoprostenol Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Epoprostenol Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Epoprostenol Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Epoprostenol Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Epoprostenol Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Epoprostenol Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Epoprostenol Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Epoprostenol Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Epoprostenol Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Epoprostenol Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Epoprostenol Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Epoprostenol Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Epoprostenol Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Epoprostenol Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Epoprostenol Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Epoprostenol by Type (2019-2025)
Table Global Consumption (K Units) of Epoprostenol by Application (2019-2025)
Table Epoprostenol Distributors List
Table Epoprostenol Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Actelion、Glaxosmithkline Inc、Sandoz Canada Incorporated、Teva Parenteral、Bayer AG、SteadyMed、Reata Pharmaceuticals、Arena Pharmaceuticals、Merck、

★調査レポート[世界のエポプロステノール市場 2019年] (コード:DATA909X07398)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のエポプロステノール市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆